FDA Inspection
BrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd. – FDA Inspection, Dec 8, 2017
Record Details
This FDA Inspection record concerns BrightGene Pharmaceutical Co., Ltd., with an inspection on December 8, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ee9f58ae-6c34-45c4-8be2-1150961abf5f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1038967
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of BrightGene Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 26, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BrightGene Pharmaceutical Co., Ltd.
- FDA Inspection 1240231 - 2024-04-26
- FDA Inspection 942083 - 2015-09-10
- FDA Inspection 831367 - 2013-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.